ClinConnect ClinConnect Logo
Search / Trial NCT05964998

Pilot Study of CBT With tDCS for Adults Being Treated for Obsessive Compulsive Disorder

Launched by ROGERS BEHAVIORAL HEALTH · Jul 19, 2023

Trial Information

Current as of June 03, 2025

Withdrawn

Keywords

Obsessive Compulsive Disorder Ocd Transcranial Direct Current Stimulation T Dcs Cognitive Behavior Therapy Cbt

ClinConnect Summary

This clinical trial is studying how a treatment called transcranial direct current stimulation (tDCS) can help adults with Obsessive-Compulsive Disorder (OCD) when used alongside cognitive-behavioral therapy (CBT). The researchers want to find out if active tDCS can lead to greater improvements in OCD symptoms compared to a placebo (sham stimulation), which is a treatment that doesn’t have any real effect. If you or someone you know is between the ages of 18 and 74, lives in Wisconsin, and is enrolled in an OCD Intensive Outpatient Program at Rogers Behavioral Health in Oconomowoc, WI, you might be eligible to participate.

Participants in this study will receive either active tDCS or the sham treatment before their CBT sessions. It's important to note that people with certain medical conditions, such as having metal implants in their body or those taking specific medications, won’t be able to join the study. This trial is currently recruiting participants, and those who take part will be helping researchers understand if combining tDCS with CBT can make a significant difference in treating OCD symptoms.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Primary diagnosis of Obsessive-Compulsive Disorder (OCD)
  • Resident of state of Wisconsin
  • Enrolled in OCD Intensive Outpatient Program (IOP) at Rogers Behavioral Health in Oconomowoc, WI
  • Ability to communicate effectively using written and spoken English
  • Exclusion Criteria:
  • Metal in the body of any kind (e.g., braces, pacemakers, metal plates or screws, intracranial electrodes, implanted devices/defibrillators, prostheses)
  • Currently taking medication that reduces seizure threshold (e.g., clomipramine)
  • Cranial pathologies (e.g., holes, plates)
  • History of seizure or black-out concussion
  • Pregnancy
  • Previous treatment at Rogers Behavioral Health

About Rogers Behavioral Health

Rogers Behavioral Health is a leading provider of specialized mental health services, dedicated to delivering evidence-based treatment for individuals struggling with a range of psychological disorders. With a strong commitment to research and innovation, Rogers Behavioral Health actively sponsors clinical trials aimed at advancing the understanding and efficacy of therapeutic interventions. The organization integrates a multidisciplinary approach, leveraging the expertise of clinicians, researchers, and support staff to enhance patient outcomes and contribute to the field of behavioral health. Through its rigorous clinical trials, Rogers seeks to improve treatment methodologies and expand access to high-quality care for those affected by mental health challenges.

Locations

Oconomowoc, Wisconsin, United States

Patients applied

0 patients applied

Trial Officials

Bradley C Riemann, PhD

Principal Investigator

Rogers Behavioral Health

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported